Skip to main content
Krka logo

Krka — Investor Relations & Filings

Ticker · KRKG ISIN · SI0031102120 LEI · 549300H9RLRTRTLRUZ73 LJSE Manufacturing
Open in API
Filings indexed 1,887 across all filing types
Latest filing 2018-11-22 Interim / Quarterly Rep…
Country SI Slovenia
Listing LJSE KRKG

About Krka

https://www.krka.biz/en/

Krka is an international generic pharmaceutical company engaged in the development, production, marketing, and sales of human and animal health products. The company's core business is focused on generic prescription pharmaceuticals, which it markets under its own brands. Its product portfolio is complemented by a range of non-prescription products and a comprehensive line of animal health products. With a history spanning over 70 years, Krka is committed to providing high-quality, effective, and safe products to a global market, aiming to contribute to a better quality of life.

Recent filings

Filing Released Lang Actions
Unaudited Interim Report for the Krka Group and Krka, d. d. for the Period from January to September 2018
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Unaudited Interim Report for the Krka Group and Krka, d. d. for the Period from January to September 2018'. It contains comprehensive financial statements, including the Statement of Financial Position, Income Statement, and Cash Flow statements for both the Group and the parent company. It also includes detailed business performance analysis, management commentary, and notes to the financial statements. As it covers a period shorter than a full fiscal year (January to September) and contains substantive financial data, it is classified as an Interim/Quarterly Report. 9M 2018
2018-11-22 Polish
Change in total number of shares with voting rights
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document explicitly states its category as 'Total number of voting rights and capital' and details the 'Change in total number of shares with voting rights' as of October 31, 2018. It lists the total issued shares, treasury shares, and total shares with voting rights. This content directly relates to the company's capital structure and shareholder rights reporting, which aligns best with the 'Declaration of Voting Results & Voting Rights Announcements' (DVA) category, as it reports the final count of voting rights. Although it is a capital structure update, DVA is more specific for voting rights counts than CAP (Capital/Financing Update). The document is short and provides definitive figures, not an announcement of a future report.
2018-11-06 English
Sprememba skupnega števila delnic z glasovalno pravico
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is written in Slovenian and its title translates to 'Change in the total number of shares with voting rights' ('Sprememba skupnega števila delnic z glasovalno pravico'). It explicitly details the total number of issued shares, treasury shares, and shares with voting rights as of a specific date (31. 10. 2018). This content directly relates to changes in the company's capital structure concerning voting rights, which aligns best with the 'Share Issue/Capital Change' definition (SHA). Although it mentions voting rights, it is a factual update on the share count, not the results of a vote (DVA) or a general announcement of a report (RPA/RNS). Given the specific nature of reporting the total number of voting shares, SHA is the most precise fit.
2018-11-06 Slovene
Acquisition of treasury shares
Transaction in Own Shares Classification · 100% confidence The document explicitly states its category as 'Acquisition or disposal of the issuer's own shares' and details the 'Acquisition of treasury shares' during a specific period (19 October 2018 up to and including 22 October 2018). This directly matches the definition for 'Transaction in Own Shares' (POS), which covers company buybacks.
2018-10-25 English
Pridobivanje lastnih delnic
Transaction in Own Shares Classification · 100% confidence The document text is titled 'Pridobivanje lastnih delnic' (Acquisition of own shares) and explicitly details transactions involving the company buying back its own shares ('odkupila 267 lastnih delnic'). It reports the number of shares held before and after the transactions. This directly corresponds to the definition of 'Transaction in Own Shares' (POS), which covers share repurchases.
2018-10-25 Slovene
Litigation relating to esomeprazole in Denmark
Legal Proceedings Report Classification · 98% confidence The document text discusses a specific legal matter: litigation concerning a patent infringement related to esomeprazole in Denmark involving Krka's subsidiary and AstraZeneca. It details the court decisions (first instance and appeal) and the finality of the High Court's ruling. This content directly relates to significant lawsuits or regulatory actions involving the company. Therefore, it fits the definition of a Legal Proceedings Report (LTR). The document is short and appears to be an official disclosure of a legal outcome, not just an announcement of a report.
2018-10-22 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.